What is Ripple Science?
Founded in 2016 and headquartered in Ann Arbor, Michigan, Ripple Science provides a specialized web-based platform designed to streamline the clinical research lifecycle. The company's software suite offers comprehensive tools for recruitment campaign management, participant tracking, and task coordination. By centralizing these workflows, Ripple Science addresses the persistent inefficiencies in patient enrollment and retention, effectively serving as a digital backbone for CROs and academic research institutions. Its market position is defined by its ability to bridge the gap between complex study requirements and operational execution, ensuring that research teams can maintain high-quality data standards while optimizing their recruitment pipelines.
How much funding has Ripple Science raised?
Ripple Science has raised a total of $4.3M across 2 funding rounds:
Angel/Seed
$1.8M
Other Financing Round
$2.5M
Angel/Seed (2019): $1.8M, investors not publicly disclosed
Other Financing Round (2020): $2.5M led by Dundee VC, Red Cedar Ventures, Mercury Fund, M25, Revolution’s Rise to the Rest Seed Fund, and SpringTime Ventures
Key Investors in Ripple Science
Mercury Fund
A venture capital firm focused on early-stage startups, particularly those building software-as-a-service platforms in the middle-market enterprise sector.
M25
A Midwest-focused venture capital firm that invests in high-growth technology companies, providing both capital and operational support to early-stage ventures.
Dundee VC
An investment firm specializing in early-stage technology companies, with a strong emphasis on supporting founders in underserved geographic markets.
What's next for Ripple Science?
With this major enterprise-level funding, Ripple Science is well-positioned to scale its operations and enhance its software capabilities. The company is expected to focus on deepening its integration with existing clinical trial management systems and expanding its footprint within the global research community. As the demand for decentralized and patient-centric clinical trials grows, Ripple Science's focus on participant engagement and data-driven recruitment will likely serve as a key differentiator. Future strategic initiatives will likely involve the deployment of advanced analytics to further reduce the time-to-enrollment for complex studies, thereby accelerating the pace of medical innovation.
See full Ripple Science company page
